Effect of Repeated Remote Ischemic Preconditioning on Peripheral Arterial Disease in Patients Suffering from Intermittent Claudication
Table 1
General characteristics of patients with intermittent claudication.
RIPC-group ( = 31)
Non/RIPC-group ( = 32)
-value
Age (years)
63.5 ± 9.0
62.2 ± 7.5
0.27
Male gender (%)
77.4
68.8
0.31
PAD evolution (months)
42.2 ± 14.1
41.6 ± 14.9
0.83
Body mass index (kg/m2)
25.9 ± 2.3
24.6 ± 2.6
0.98
Ankle-brachial index
0.62 ± 0.1
0.63 ± 0.1
0.87
Hypertension (%)
61.3
62.5
>0.05
Diabetes mellitus (%)
35.5
34.4
>0.05
Dyslipidemia (%)
36.5
37.5
>0.05
Current smoker (%)
61.9
62.5
>0.05
Revascularization history (%)
22.2
21.9
>0.05
Atherosclerosis CAD (%)
15.9
15.6
>0.05
Aspirin (%)
71.4
65.6
>0.05
P2Y12 inhibitors (%)
54.8
53.1
>0.05
Statins (%)
49.2
50.0
>0.05
Beta-blockers (%)
28.6
28.1
>0.05
Antihypertensive drugs (%)
58.7
59.4
>0.05
Insulin (%)
28.6
28.1
>0.05
Cilostazol (%)
17.5
18.8
>0.05
Distribution of the peripheral arterial lesions (%)
>0.05
SFA
41.9
40.6
Popliteal artery
9.6
12.5
ATA
54.8
50.0
PA
25.8
21.8
PTA
51.6
43.7
Presence of bilateral lesion (%)
45.1
46.8
>0.05
Data are expressed as mean ± standard deviation, number (%) or median (25th–75th percentile). PAD: Peripheral artery disease; CAD: Carotid artery disease; SFA: Superficial femoral artery; ATA: Anterior tibial artery; PA: Peroneal artery; PTA: Posterior tibial artery.
